CT导向下瘤内碘油阿霉素乙醇注射治疗肝癌30例疗效分析  

CT-guided Percutaneous Intratumorous Injection of Lipiodol- adriamycin-ethanol for Treatment of Liver Cancer

作　　者：吴建兵[1] 倪恿文[1] 黄平[1] 李晓[2] 汪青山[2] 

机构地区：[1]江西医学院第二附属医院肿瘤科,江西南昌330006 [2]江西医学院第二附属医院CT室,江西南昌330006

出　　处：《江西医学院学报》2000年第3期45-47,共3页Acta Academiae Medicinae Jiangxi

摘　　要：目的 :探讨CT导向下碘油阿霉素乙醇注射治疗肝癌的疗效。方法 :在CT导向下 ,用碘油阿霉素乙醇混合物直接注入瘤体内进行治疗 ,每隔 7～ 10d重复注射一次 ,共注射 3～ 4次为一疗程。结果 :<3cm、3～ 5cm和 >5cm直径肝癌患者的 1年生存率为 10 0 %、6 6 .6 %和 90 .0 % ;3年生存率为 40 .0 %、6 2 .5 %和 12 .5 %。组织学检查70 .0 %的病灶完全坏死 ,未发生严重并发症。结论 :该方法疗效确切 ,适应症广 ,副作用小 ,患者易于接受。Objective: To study the therapeutic effect of CT-guided percutaneous intratumorous injection of lipiodol-adriamycin-ethanol for treatment of liver cancer. Methods: Under the guidance of CT, the lipiodol-adriamycin-ethanol was injected directly into the tumor. With the intervals of 7 to 10 days, the injection was repeated again and the course of treatment included 3 to 4 injections. Results: The 1- and 3-years survival rates of the patients with tumors of less than 3 cm, 3 to 5 cm and more than 5 cm in diameter were 100%, 66.6%; 90%, 40% and 62.5%, 12.5% respectively without serious complications. Histological examination showed complete necrosis was seen in 70% of tumors treated. Conclusion: This therapeutic method was effectiveness, wide rang of application, minimum side effect and accepted easily by patients with liver cancer.

关 键 词：肝肿瘤 CT 介入治疗 药物疗法 

分 类 号：R735.7[医药卫生—肿瘤] R979.1[医药卫生—临床医学]